RA CAPITAL MANAGEMENT, L.P. 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
RC
RA CAPITAL MANAGEMENT, L.P.
Institutional Filer 3.31%$9.44B85

Current Portfolio Holdings

Showing all 85 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1ASNDAscendis Pharma A/SHealthcare10.3M$2.35B24.92%
2PCVXVaxcyte, Inc.Healthcare11.5M$666.8M7.07%
3RYTMRhythm Pharmaceuticals, Inc.Healthcare6.7M$579.8M6.14%
4TYRATyra Biosciences, Inc.Healthcare12.2M$467.2M4.95%
5SIONSionna Therapeutics, Inc.Healthcare9.9M$397.1M4.21%
6EWTXEdgewise Therapeutics, Inc.Healthcare10.4M$328.5M3.48%
7NAMSNewAmsterdam Pharma Company N.V.Healthcare9.6M$305.7M3.24%
8NUVLNuvalent, Inc.Healthcare2.5M$259.6M2.75%
9DNTHDianthus Therapeutics, Inc.Healthcare2.6M$219.2M2.32%
10MLYSMineralys Therapeutics, Inc.Healthcare7.7M$208.4M2.21%
11SGPSPYGLASS PHARMA INC8.0M$207.8M2.20%
12WVEWave Life Sciences Ltd.Healthcare27.0M$195.6M2.07%
13SEPNSepterna, Inc.Healthcare7.0M$168.1M1.78%
14IRONDisc Medicine, Inc.Healthcare2.5M$156.7M1.66%
15JANXJanux Therapeutics, Inc.Healthcare11.2M$155.5M1.65%
Showing 1 to 15 of 85 holdings